E-LIB Suche - Ergebnisse für: Michels, Sebastian Y. F.

1

ALK G1269A mutation as a potential mechanism of acquired re..:

Michels, Sebastian Y. F. ; Scheel, Andreas H. ; Wündisch, Thomas...
npj Precision Oncology. 1 (2017) 1 - p. , 2017

2

ALKG1269A mutation as a potential mechanism of acquired res..:

Michels, Sebastian Y. F ; Scheel, Andreas H ; Wündisch, Thomas...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5871789/. , 2017

Link: http://www.ncbi.nlm.nih...

3

ALK G1269A mutation as a potential mechanism of acquired re..:

Sebastian Y. F. Michels ; Andreas H. Scheel ; Thomas Wündisch...
https://doi.org/10.1038/s41698-017-0004-3. , 2017

Link: https://doi.org/10.1038/..

4

Safety and Efficacy of Crizotinib in Patients With Advanced..:

Michels, Sebastian ; Massutí, Bartomeu ; Schildhaus, Hans-Ulrich...
http://hdl.handle.net/10668/13819. , 2019

Link: http://hdl.handle.net/10..

5

Safety and Efficacy of Crizotinib in Patients With Advanced..:

Michels, Sebastian ; Massuti, Bartomeu ; Schildhaus, Hans-Ulrich...
Michels , S , Massuti , B , Schildhaus , H-U , Franklin , J , Sebastian , M , Felip , E , Grohe , C , Rodriguez-Abreu , D , Abdulla , D S Y , Bischoff , H , Brandts , C , Carcereny , E , Corral , J , Dingemans , A-M C , Pereira , E , Fassunke , J , Fischer , R N , Gardizi , M , Heukamp , L , Insa , A , Kron , A , Menon , R , Persigehl , T , Reck , M , Riedel , R , Rothschild , S I , Scheel , A H , Scheffler , M , Schmalz , P , Smit , E F , Limburg , M , Provencio , M , Karachaliou , N , Merkelbach-Bruse , S , Hellmich , M , Nogova , L , Buettner , R , Rosell , R & Wolf , J 2019 , ' Safety and Efficacy of Crizotinib in Patients With Advanced or Metastatic ROS1-Rearranged Lung Cancer (EUCROSS) : A European Phase II Clinical Trial ' , Journal of Thoracic Oncology , vol. 14 , no. 7 , pp. 1266-1276 . https://doi.org/10.1016/j.jtho.2019.03.020. , 2019

Link: https://cris.maastrichtu..

6

3131 Clinical and molecular characteristics of non-small ce..:

Gogl, L. ; Scheffler, M. ; Ihle, M....
European Journal of Cancer. 51 (2015) - p. S647 , 2015

Link: https://doi.org/10.1016/..

7

Clonal dynamics of BRAF-driven drug resistance in EGFR-muta..:

Schaufler, Diana ; Ast, David F. ; Tumbrink, Hannah L....
npj Precision Oncology. 5 (2021) 1 - p. , 2021

Link: https://doi.org/10.1038/..

8

Sorafenib and everolimus in patients with advanced solid tu..:

Nogova, Lucia ; Mattonet, Christian ; Scheffler, Matthias...
Cancer Medicine. 9 (2020) 14 - p. 4991-5007 , 2020

Link: https://doi.org/10.1002/..

9

Co-occurrence of targetable mutations in Non-small cell lun..:

Scheffler, Matthias ; Holzem, Alessandra ; Kron, Anna...
Lung Cancer. 144 (2020) - p. 40-48 , 2020

Link: https://doi.org/10.1016/..

10

K-ras Mutation Subtypes in NSCLC and Associated Co-occuring..:

Scheffler, Matthias ; Ihle, Michaela A. ; Hein, Rebecca...
Journal of Thoracic Oncology. 14 (2019) 4 - p. 606-616 , 2019

Link: https://doi.org/10.1016/..

11

Acquired KRAS mutation and loss of low-level MET amplificat..:

Riedel, Richard ; Michels, Sebastian ; Heydt, Carina...
Lung Cancer. 133 (2019) - p. 20-22 , 2019

Link: https://doi.org/10.1016/..

12

Monitoring Treatment Response to Erlotinib in EGFR-mutated ..:

Abdulla, Diana S.Y. ; Scheffler, Matthias ; Brandes, Vanessa...
Clinical Lung Cancer. 20 (2019) 2 - p. e148-e151 , 2019

Link: https://doi.org/10.1016/..

13

TAMEP are brain tumor parenchymal cells controlling neoplas..:

Kälin, R. ; Cai, L. ; Li, Y....
Brain and Spine. 1 (2021) - p. 100468 , 2021

Link: https://doi.org/10.1016/..

14

Consensus in chronic ankle instability: Aetiology, assessme..:

Guillo, S. ; Bauer, T. ; Lee, J.W....
Orthopaedics & Traumatology: Surgery & Research. 99 (2013) 8 - p. S411-S419 , 2013

Link: https://doi.org/10.1016/..

15

Association between dexamethasone treatment and the host re..:

de Brabander, Justin ; Michels, Erik H. A. ; van Linge, Christine C. A....
Respiratory Research. 23 (2022) 1 - p. , 2022

Link: https://doi.org/10.1186/..